Farah Arafat
Physician Assistant · Royal Oak, MINPI 1992118152
Payments from drug & device makers
Across 500 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$952
- Regeneron Healthcare Solutions, Inc.$783
- Optinose US, Inc.$698
- Amgen$650
- CSL Behring$637
- plus $3K from 22 others
What the payments were for
- Food & beverage$9,91799%
- Education$1401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 130 | $2,969 |
| GSK | 76 | $952 |
| Regeneron Healthcare Solutions, Inc. | 32 | $783 |
| Optinose US, Inc. | 31 | $698 |
| Amgen | 47 | $650 |
| CSL Behring | 29 | $637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $503 |
| Pfizer | 22 | $474 |
| Sanofi | 16 | $364 |
| Novartis | 18 | $349 |
| Alk-abello, Inc | 13 | $275 |
| Boehringer Ingelheim | 14 | $242 |
| Kaleo, Inc. | 12 | $222 |
| Pharming Healthcare, Inc. | 7 | $179 |
| AbbVie | 6 | $121 |
| Biocryst US Sales Co., LLC | 4 | $107 |
| Grifols USA, LLC | 3 | $94 |
| LEO Pharma Inc. | 4 | $79 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| Incyte Corporation | 2 | $51 |
| Organon | 3 | $45 |
| Genentech USA, Inc. | 2 | $35 |
| Blueprint Medicines Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| Hospira, Inc. | 1 | $19 |
| Bio Products Laboratory USA, Inc. | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,057 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $34,741 |
| Spiriva RespimatTiotropium Bromide | 54 | $27,269 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $11,394 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 59 | $8,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,716 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $7,375 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 42 | $6,776 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $6,310 |
| Azelastine Hcl | 151 | $4,731 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,799 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $3,733 |
| Montelukast Sodium | 323 | $2,233 |
| Ventolin HfaAlbuterol Sulfate | 32 | $1,885 |
| Fluticasone Propionate | 119 | $1,803 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 15 | $970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $952 | $49,93479 claims |
| Boehringer IngelheimSpiriva Respimat | $242 | $27,26954 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,969 | $15,09143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Royal Oak
- Sarang PatelRoyal Oak$660K
- Gabrielle DamoreRoyal Oak$200K
- Laura KingRoyal Oak$63K
- Inge HanschuRoyal Oak$21K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.